Alandag Celal
- 17 tahun pengalaman
- Lokasi: Turquia, Sivas
Bandingkan dokter dan harga Kemoterapi untuk kanker prostat teratas di Turquia. Temukan pencocokan terbaik Anda di sini.
Kami akan memilih dokter terbaik berdasarkan kebutuhan dan anggaran Anda.
Ditinjau secara medis oleh Fahad Mawlood
Editor Medis & Data ScientistDokter teratas
2
Turquia
Ulasan
14000+
Dari pasien asli
Bandingkan harga untuk Kemoterapi untuk kanker prostat di negara-negara teratas
Ketuk negara untuk melihat dokter teratas dan harga
Dapatkan rencana perawatan yang dipersonalisasi gratis dan pilih opsi terbaik. Tanpa komitmen · Tidak ada pembayaran untuk layanan kami
Memilih klinik di luar negeri bisa membuat stres. Di Bookimed, dengan 800.000+ pasien telah dibantu, kami memahami kekhawatiran Anda. Kami tahu cara menemukan dokter terpercaya, opsi harga terbaik, dan solusi bahkan untuk kasus yang rumit. Kami siap membimbing Anda di setiap langkah.
Yan Matsiivskiy
Kepala Tim Koordinator Medis
4300++ perjalanan pasien yang dipandu
3 tahun di Bookimed
278 pasien dari Turkey telah menemukan dokternya melalui kami bulan ini
Kuis 2 menit
Ceritakan tujuan, anggaran, dan waktu Anda
Pencocokan Manusia + AI
Algoritme kami menemukan kecocokan, koordinator memverifikasi kesesuaian
Pilihan Anda Siap
Bandingkan harga, paket, tanggal. Chat dengan koordinator Anda
Bingung dengan banyak pilihan?
Membimbing pengobatan Anda
Koordinator pribadi berpengalaman medis






| Peringkat | Dokter | pengalaman | Cocok Untuk | Apa yang Membedakan Mereka | Klinik & Lokasi | Konsultasi |
|---|
Top medical oncologists in Turkey for prostate cancer hold certifications from the European Society for Medical Oncology (ESMO). Specialists like Dr. Mustafa Solak and Dr. Yesim Yildirim treat advanced cases at JCI-accredited centers. These doctors often have training from MD Anderson or Rambam Medical Center.
Bookimed Expert Insight: Data shows a high concentration of urological cancer specialists at Anadolu Medical Center. Dr. Eda Tanrikulu ranked 3rd in Turkey's national oncology exam, highlighting the competitive academic rigor. Patients can access consultations with these experts starting from $100 to around $215.
Patient Consensus: Patients note that getting a second opinion on pathology is vital before starting chemotherapy. They appreciate oncologists who are direct about side effects like fatigue or neuropathy. Many felt more confident when their doctor personally managed complex sequencing for metastatic cases.
Turkish prostate cancer specialists must hold a Medical Oncology Specialty License after completing a specific internal medicine residency and a three-year oncology fellowship. Look for professors with ESMO certification and international training from institutions like MD Anderson or Cleveland Clinic.
Bookimed Expert Insight: Data shows that leading Turkish oncologists often hold dual certifications and international research background. For instance, Dr. Yesim Yildirim and Dr. Seref Komurcu are both ESMO-certified with over 20 years of experience. Dr. Cemil Bilir and Dr. Mustafa Solak gained expertise at prestigious US institutions like the Cleveland Clinic and MD Anderson, offering patients access to global treatment protocols in Istanbul.
Patient Consensus: Patients note it is important to find an oncologist who explains hormone and chemotherapy sequencing in plain language. Many emphasize choosing a specialist at hospitals with tumor boards to ensure all doctors coordinate the treatment plan together. Families often feel relieved when the doctor has specific experience managing side effects for advanced cancer cases.
Turkey's top specialists in prostate cancer chemotherapy practice at JCI-accredited centers in Istanbul and Antalya. These institutions feature multidisciplinary tumor boards and ESMO-certified departments. Leading oncologists hold fellowships from institutions like MD Anderson and the Cleveland Clinic to manage complex systemic treatments.
Bookimed Expert Insight: Data shows a strong trend of international training among Turkey's medical oncology leaders. For instance, Dr. Mustafa Solak and Dr. Cemil Bilir trained at top-tier US institutions like MD Anderson and the Cleveland Clinic. This exposure allows them to implement the latest global chemotherapy sequencing for aggressive, castration-resistant cases.
Patient Consensus: Patients emphasize that successful treatment depends on choosing hospitals with in-house PSMA PET-CT and pathology labs. They note that having all diagnostics under one roof prevents delays in starting chemotherapy cycles. Many were relieved to find that major centers provide English-speaking coordinators to explain each step of the plan.